Founder, CEO & President

Dr. Redelmeier has more than 30 years of experience studying lipid nanoparticle systems including 20 years at Transferra where he was involved with more than 30 programs that were in preclinical and/or clinical development. He completed his PhD studies at the University of British Columbia, working with Dr. Pieter Cullis. He is the author of more than 25 peer reviewed papers, and has co-authored a book on Percutaneous Absorption (Karger 1996).

Prior to joining Cuprous, Dr. Redelmeier was the President & CEO of Transferra Nanosciences (formerly known as Northern Lipids). He led the company for 20 years, transforming it into a leader in the provision of Contract Research/Manufacturing services specifically related to lipid nanoparticle formulations of active pharmaceutical ingredients. The company was sold to EVONIK in 2016, where it continues to be active in this area.